Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

نویسندگان

  • Antonis C Antoniou
  • Christiana Kartsonaki
  • Olga M Sinilnikova
  • Penny Soucy
  • Lesley McGuffog
  • Sue Healey
  • Andrew Lee
  • Paolo Peterlongo
  • Siranoush Manoukian
  • Bernard Peissel
  • Daniela Zaffaroni
  • Elisa Cattaneo
  • Monica Barile
  • Valeria Pensotti
  • Barbara Pasini
  • Riccardo Dolcetti
  • Giuseppe Giannini
  • Anna Laura Putignano
  • Liliana Varesco
  • Paolo Radice
  • Phuong L Mai
  • Mark H Greene
  • Irene L Andrulis
  • Gord Glendon
  • Hilmi Ozcelik
  • Mads Thomassen
  • Anne-Marie Gerdes
  • Torben A Kruse
  • Uffe Birk Jensen
  • Dorthe G Crüger
  • Maria A Caligo
  • Yael Laitman
  • Roni Milgrom
  • Bella Kaufman
  • Shani Paluch-Shimon
  • Eitan Friedman
  • Niklas Loman
  • Katja Harbst
  • Annika Lindblom
  • Brita Arver
  • Hans Ehrencrona
  • Beatrice Melin
  • Katherine L Nathanson
  • Susan M Domchek
  • Timothy Rebbeck
  • Ania Jakubowska
  • Jan Lubinski
  • Jacek Gronwald
  • Tomasz Huzarski
  • Tomasz Byrski
  • Cezary Cybulski
  • Bohdan Gorski
  • Ana Osorio
  • Teresa Ramón y Cajal
  • Florentia Fostira
  • Raquel Andrés
  • Javier Benitez
  • Ute Hamann
  • Frans B Hogervorst
  • Matti A Rookus
  • Maartje J Hooning
  • Marcel R Nelen
  • Rob B van der Luijt
  • Theo A M van Os
  • Christi J van Asperen
  • Peter Devilee
  • Hanne E J Meijers-Heijboer
  • Encarna B Gómez Garcia
  • Susan Peock
  • Margaret Cook
  • Debra Frost
  • Radka Platte
  • Jean Leyland
  • D Gareth Evans
  • Fiona Lalloo
  • Ros Eeles
  • Louise Izatt
  • Julian Adlard
  • Rosemarie Davidson
  • Diana Eccles
  • Kai-ren Ong
  • Jackie Cook
  • Fiona Douglas
  • Joan Paterson
  • M John Kennedy
  • Zosia Miedzybrodzka
  • Andrew Godwin
  • Dominique Stoppa-Lyonnet
  • Bruno Buecher
  • Muriel Belotti
  • Carole Tirapo
  • Sylvie Mazoyer
  • Laure Barjhoux
  • Christine Lasset
  • Dominique Leroux
  • Laurence Faivre
  • Myriam Bronner
  • Fabienne Prieur
  • Catherine Nogues
  • Etienne Rouleau
  • Pascal Pujol
  • Isabelle Coupier
  • Marc Frénay
  • John L Hopper
  • Mary B Daly
  • Mary B Terry
  • Esther M John
  • Saundra S Buys
  • Yosuf Yassin
  • Alexander Miron
  • David Goldgar
  • Christian F Singer
  • Muy-Kheng Tea
  • Georg Pfeiler
  • Anne Catharina Dressler
  • Thomas v O Hansen
  • Lars Jønson
  • Bent Ejlertsen
  • Rosa Bjork Barkardottir
  • Tomas Kirchhoff
  • Kenneth Offit
  • Marion Piedmonte
  • Gustavo Rodriguez
  • Laurie Small
  • John Boggess
  • Stephanie Blank
  • Jack Basil
  • Masoud Azodi
  • Amanda Ewart Toland
  • Marco Montagna
  • Silvia Tognazzo
  • Simona Agata
  • Evgeny Imyanitov
  • Ramunas Janavicius
  • Conxi Lazaro
  • Ignacio Blanco
  • Paul D P Pharoah
  • Lara Sucheston
  • Beth Y Karlan
  • Christine S Walsh
  • Edith Olah
  • Aniko Bozsik
  • Soo-Hwang Teo
  • Joyce L Seldon
  • Mary S Beattie
  • Elizabeth J van Rensburg
  • Michelle D Sluiter
  • Orland Diez
  • Rita K Schmutzler
  • Barbara Wappenschmidt
  • Christoph Engel
  • Alfons Meindl
  • Ina Ruehl
  • Raymonda Varon-Mateeva
  • Karin Kast
  • Helmut Deissler
  • Dieter Niederacher
  • Norbert Arnold
  • Dorothea Gadzicki
  • Ines Schönbuchner
  • Trinidad Caldes
  • Miguel de la Hoya
  • Heli Nevanlinna
  • Kristiina Aittomäki
  • Martine Dumont
  • Jocelyne Chiquette
  • Marc Tischkowitz
  • Xiaoqing Chen
  • Jonathan Beesley
  • Amanda B Spurdle
  • Susan L Neuhausen
  • Yuan Chun Ding
  • Zachary Fredericksen
  • Xianshu Wang
  • Vernon S Pankratz
  • Fergus Couch
  • Jacques Simard
  • Douglas F Easton
  • Georgia Chenevix-Trench
چکیده

Two single nucleotide polymorphisms (SNPs) at 6q25.1, near the ESR1 gene, have been implicated in the susceptibility to breast cancer for Asian (rs2046210) and European women (rs9397435). A genome-wide association study in Europeans identified two further breast cancer susceptibility variants: rs11249433 at 1p11.2 and rs999737 in RAD51L1 at 14q24.1. Although previously identified breast cancer susceptibility variants have been shown to be associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers, the involvement of these SNPs to breast cancer susceptibility in mutation carriers is currently unknown. To address this, we genotyped these SNPs in BRCA1 and BRCA2 mutation carriers from 42 studies from the Consortium of Investigators of Modifiers of BRCA1/2. In the analysis of 14 123 BRCA1 and 8053 BRCA2 mutation carriers of European ancestry, the 6q25.1 SNPs (r(2) = 0.14) were independently associated with the risk of breast cancer for BRCA1 mutation carriers [hazard ratio (HR) = 1.17, 95% confidence interval (CI): 1.11-1.23, P-trend = 4.5 × 10(-9) for rs2046210; HR = 1.28, 95% CI: 1.18-1.40, P-trend = 1.3 × 10(-8) for rs9397435], but only rs9397435 was associated with the risk for BRCA2 carriers (HR = 1.14, 95% CI: 1.01-1.28, P-trend = 0.031). SNP rs11249433 (1p11.2) was associated with the risk of breast cancer for BRCA2 mutation carriers (HR = 1.09, 95% CI: 1.02-1.17, P-trend = 0.015), but was not associated with breast cancer risk for BRCA1 mutation carriers (HR = 0.97, 95% CI: 0.92-1.02, P-trend = 0.20). SNP rs999737 (RAD51L1) was not associated with breast cancer risk for either BRCA1 or BRCA2 mutation carriers (P-trend = 0.27 and 0.30, respectively). The identification of SNPs at 6q25.1 associated with breast cancer risk for BRCA1 mutation carriers will lead to a better understanding of the biology of tumour development in these women.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Germline mutations in BRCA1 and BRCA2 confer high risks of breast cancer. However, evidence suggests that these risks are modified by other genetic or environmental factors that cluster in families. A recent genome-wide association study has shown that common alleles at single nucleotide polymorphisms (SNPs) in FGFR2 (rs2981582), TNRC9 (rs3803662), and MAP3K1 (rs889312) are associated with incr...

متن کامل

Women with hereditary breast cancer predispositions should avoid using their smartphones, tablets and laptops at night

Breast cancer is the most common malignancy among women, both in the developed and developing countries. Women with mutations in the BRCA1 and BRCA2 genes have an increased risk of breast and ovarian cancers. Recent studies show that short-wavelength visible light disturb the secretion of melatonin and causes circadian rhythm disruption. We have previously studied the health effects of exposure...

متن کامل

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

BACKGROUND Reliable estimates of cancer risk are critical for guiding management of BRCA1 and BRCA2 mutation carriers. The aims of this study were to derive penetrance estimates for breast cancer, ovarian cancer, and contralateral breast cancer in a prospective series of mutation carriers and to assess how these risks are modified by common breast cancer susceptibility alleles. METHODS Prospe...

متن کامل

بررسی موتاسیون های شایع ژن BRCA1 و BRCA2 در دختران مادران مبتلا به سرطان سینه و مقایسه آن با گروه کنترل

Background and purpose: Breast Cancer is one of the health problems in every population. The aim of this study was to determine the frequency of BRCA1 and BRCA2 common mutations in women whose mothers were diagnosed with breast cancer. Materials and methods: A case–control study was performed in 109 females (less than 40 years of age) who had mothers with breast cancer. For scanning of...

متن کامل

The Potential Contribution of BRCA Mutations to Early Onset and Familial Breast Cancer in Uzbekistan

Introuduction Breast cancer is the most common malignancy in women and affects approximately 1 out of 8 females in the US. Risk of developing breast cancer is strongly influenced by genetic factors. Germ-line mutations in BRCA1 and BRCA2 genes are associated with 5-10% of breast cancer incidence. To reduce the risk of developing cancer and to increase the likelihood of early detection, carriers...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Human molecular genetics

دوره 20 16  شماره 

صفحات  -

تاریخ انتشار 2011